Skip to Content

BNY Mellon International Stock Index Inv DIISX

Medalist Rating as of | See BNY Mellon Investment Hub
  • NAV / 1-Day Return 20.16  /  −0.44 %
  • Total Assets 339.7 Mil
  • Adj. Expense Ratio
    0.600%
  • Expense Ratio 0.600%
  • Distribution Fee Level Below Average
  • Share Class Type No Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 3.00%
  • Turnover 2%

USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 11:46 PM GMT+0

Morningstar’s Analysis DIISX

Will DIISX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

BNY Mellon International Stock Index Inv’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings DIISX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 15.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

2.25 7.3 Mil
Healthcare

ASML Holding NV

2.08 6.8 Mil
Technology

Nestle SA

1.84 6.0 Mil
Consumer Defensive

Msci Eafe Mar24

1.51 4.9 Mil

Lvmh Moet Hennessy Louis Vuitton SE

1.38 4.5 Mil
Consumer Cyclical

Dreyfus Instl Preferred Gov Plus MMkt

1.35 4.4 Mil
Cash and Equivalents

Novartis AG Registered Shares

1.28 4.2 Mil
Healthcare

Toyota Motor Corp

1.27 4.1 Mil
Consumer Cyclical

AstraZeneca PLC

1.24 4.1 Mil
Healthcare

Shell PLC

1.24 4.0 Mil
Energy